The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Guides and Reports
As the health care industry is continuing to evolve, many industry leaders are looking to build a more resilient supply chain by asking, “What coul
White Papers
Healthcare expenses continue to rise and yet hospitals are realizing consistently shrinking margins.
e-Learning
Enhance your knowledge of health care supply chain management with our Introduction to Health Care Supply Chain course. Improve patient care and…
Webcast
Crises can stress even the strongest leaders.
On-Demand Educational Webinars
Consider how the four emerging themes on purchased services and their leading practices can deliver improved margins.
AHRMM20+ Cost, Quality and Outcomes (CQO) Summit white paper describes lessons learned by health care supply chain during the COVID-19 pandemic, best…